Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK1E | P49674 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.35 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.34 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.34 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | ADH1B | P00325 | 1/20 | 0.33 |
| ▸ | ADH1C | P00326 | 1/20 | 0.33 |
| ▸ | ADH1A | P07327 | 1/20 | 0.33 |
| ▸ | ADH4 | P08319 | 1/20 | 0.33 |
| ▸ | ADH7 | P40394 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.32 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL980142 | 1.00 | CSNK1E (0.36) | CSNK1EALDH1A1KMT2AMEN1NPSR1 | |
| SCHEMBL3223557 | 1.00 | CSNK1E (0.36) | CSNK1EALDH1A1KMT2AMEN1NPSR1 | |
| SCHEMBL2958747 | 1.00 | CSNK1E (0.36) | CSNK1EALDH1A1KMT2AMEN1NPSR1 | |
| SCHEMBL984974 | 1.00 | CSNK1E (0.36) | CSNK1EALDH1A1KMT2AMEN1NPSR1 | |
| SCHEMBL984970 | 1.00 | CSNK1E (0.36) | CSNK1EALDH1A1KMT2AMEN1NPSR1 | |
| SCHEMBL983089 | 1.00 | CSNK1E (0.36) | CSNK1EALDH1A1KMT2AMEN1NPSR1 | |
| SCHEMBL815609 | 0.98 | CSNK1E (0.34) | CSNK1EALDH1A1KMT2AMEN1NPSR1 | |
| SCHEMBL815743 | 0.93 | POLB (0.34) | ALDH1A1CNR2KDM4ESMN1; SMN2 | |
| SCHEMBL534244 | 0.85 | SMN1; SMN2 (0.36) | SMN1; SMN2 | |
| SCHEMBL983413 | 0.84 | NR1I2 (0.40) | CSNK1EALDH1A1KMT2AMEN1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118302407-A | Carbonyl compound, method for producing isocyanate compound, and isocyanate composition | 旭化成株式会社 | 2024-07-05 | — | — | CN | disclosed |
| CN-118215651-A | Method for producing isocyanate compound, method for producing urethane compound, method for recovering amine compound, and isocyanate composition | 旭化成株式会社 | 2024-06-18 | — | — | CN | disclosed |
| WO-2023080258-A1 | CARBONYL COMPOUND, METHOD FOR PRODUCING CARBONYL COMPOUND, METHOD FOR PRODUCING ISOCYANATE COMPOUND, AND ISOCYANATE COMPOSITION | 旭化成株式会社 | 2023-05-11 | — | — | WO | disclosed |
| WO-2023080257-A1 | METHOD FOR PRODUCING ISOCYANATE COMPOUNDS, METHOD FOR PRODUCING CARBAMATE COMPOUNDS, METHOD FOR RECOVERING AMINE COMPOUNDS, AND ISOCYANATE COMPOSITION | 旭化成株式会社 | 2023-05-11 | — | — | WO | disclosed |
| EP-2275406-B1 | PROCESS FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND (JP) | 2018-11-28 | — | — | EP | disclosed |
| US-9233918-B2 | Isocyanate production process | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-01-12 | — | — | US | disclosed |
| EP-2088138-B1 | Process for producing isocyanate | ASAHI KASEI CHEMICALS CORP (JP) | 2013-02-27 | — | — | EP | disclosed |
| US-8362293-B2 | Process for producing isocyanates | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2013-01-29 | — | — | US | disclosed |
| US-20110092731-A1 | ISOCYANATE PRODUCTION PROCESS | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
| EP-2275406-A1 | PROCESS FOR PRODUCING ISOCYANATE | Asahi Kasei Chemicals Corporation (JP) | 2011-01-19 | — | — | EP | disclosed |
| EP-1412358-A1 | 6-(2,6-DIFLUOROPHENYL)-TRIAZOLOPYRIMIDINES AS FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2004-04-28 | — | — | EP | disclosed |
| EP-1381609-A1 | 5-HALOGEN-6-PHENYL-7-FLUOROALKYLAMINO-TRIAZOLOPYRIMIDINES AS FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-21 | — | — | EP | disclosed |
| EP-1381610-A1 | 6-(2-CHLORO-6-FLUORO-PHENYL)-TRIAZOLOPYRIMIDINES | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-21 | — | — | EP | disclosed |
| WO-2003008417-A9 | SUBSTITUTED 6-(2-TOLYL)-TRIAZOLOPYRIMIDINES AS FUNGICIDES | BASF AG (DE) | 2003-10-30 | — | — | WO | disclosed |
| WO-2003008417-A1 | SUBSTITUTED 6-(2-TOLYL)-TRIAZOLOPYRIMIDINES AS FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2003-01-30 | — | — | WO | disclosed |
| WO-2003008416-A1 | SUBSTITUTED 6-(2-METHOXYPHENYL) TRIAZOLOPYRIMIDES AS FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2003-01-30 | — | — | WO | disclosed |
| WO-2003008415-A1 | 6-(2,6-DIFLUOROPHENYL)-TRIAZOLOPYRIMIDINES AS FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2003-01-30 | — | — | WO | disclosed |
| WO-2002083677-A1 | 6-(2-CHLORO-6-FLUORO-PHENYL)-TRIAZOLOPYRIMIDINES | BASF AKTIENGESELLSCHAFT (DE) | 2002-10-24 | — | — | WO | disclosed |
| WO-2002083676-A1 | 5-HALOGEN-6-PHENYL-7-FLUORALKYLAMINO-TRIAZOLOPYRIMIDINES AS FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2002-10-24 | — | — | WO | disclosed |
| US-4178253-A | 1,2,4-TRIAZOLE COMPOUNDS | CIBA-GEIGY CORPORATION (US) | 1979-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110092731-A1 | ISOCYANATE PRODUCTION PROCESS | CPS1, PHGDH, APEH | CSNK1E 1382/4885ALDH1A1 2204/4885KMT2A 1901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.